Alpha-1 Foundation Research Registry
NCT00499941 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6655
Last updated 2021-03-03
Summary
The Alpha-1 Foundation Research Registry is a confidential database made up of individuals diagnosed with severe alpha-1 antitrypsin deficiency (Alpha-1) or the carrier state.
Conditions
Sponsors & Collaborators
-
Alpha-1 Foundation
collaborator OTHER -
Medical University of South Carolina
lead OTHER
Principal Investigators
-
Charlie Strange, M.D. · Medical University of South Carolina
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2000-04-30
- Primary Completion
- 2021-01-31
- Completion
- 2021-01-31
Countries
- United States
Study Locations
More Related Trials
-
A National Registry on Chinese Patients With Cystic Fibrosis
NCT05289245 ·Status: RECRUITING
-
Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA
NCT00585364 ·Status: COMPLETED
-
Tissue Bank for Pulmonary Diseases
NCT00546962 ·Status: UNKNOWN
-
Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group
NCT00221559 ·Status: COMPLETED
-
Diagnosis and Treatment of Patients With Cystic Fibrosis
NCT00001223 ·Status: TERMINATED
-
Analysis T Cells Response for Identification of Aspergillus Bronchitis With Cystic Fibrosis Patients
NCT02550041 ·Status: TERMINATED ·Phase: NA
-
Molecular Phenotypes for Cystic Fibrosis Lung Disease
NCT01116414 ·Status: COMPLETED
-
Gene Modifiers of Cystic Fibrosis Lung Disease
NCT00037765 ·Status: ACTIVE_NOT_RECRUITING
-
Development a Core Set for Adults With Cystic Fibrosis Based on the ICF
NCT06128499 ·Status: COMPLETED
-
Study of the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects With Alpha 1-Antitrypsin Deficiency
NCT00157092 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of Ivacaftor in Patients Using Ataluren for Nonsense Mutations
NCT03256799 ·Status: COMPLETED ·Phase: PHASE4
-
Phase II Study of the Safety and Efficacy of Inhaled Alpha-1 Antitrypsin (AAT ) in Cystic Fibrosis Patients
NCT00499837 ·Status: COMPLETED ·Phase: PHASE2
-
Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis Patients
NCT00004296 ·Status: COMPLETED
-
Combating Diagnostic Wandering and Impasse for Cystic Fibrosis
NCT05654480 ·Status: UNKNOWN
-
Idiopathic Pulmonary Fibrosis: a Case-control Study
NCT00005295 ·Status: TERMINATED
-
Small Circulating RNA as Molecular Markers of Lung Disease in Cystic Fibrosis
NCT02992080 ·Status: COMPLETED ·Phase: NA
-
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
NCT02109822 ·Status: COMPLETED
-
Breath Condensate Study in Patients With Cystic Fibrosis.
NCT02056132 ·Status: COMPLETED
-
Quantitation and Spatial Registration of Airways Dysfunction With Dynamic 19F MRI in Cystic Fibrosis
NCT06057714 ·Status: RECRUITING
-
A Two-Part Multicenter Prospective Longitudinal Study of CFTR-dependent Disease Profiling in Cystic Fibrosis (PROSPECT)
NCT02477319 ·Status: COMPLETED
-
Cystic Fibrosis Related Bone Disease: the Role of CFTR
NCT01549314 ·Status: COMPLETED
-
Evaluation of Salt Status in Patients With Cystic Fibrosis
NCT04556162 ·Status: COMPLETED
-
Cystic Fibrosis and Cognitive Function
NCT03820349 ·Status: COMPLETED
-
Discovering Trends in Chronic Fatigue Syndrome Patients' Clinical Study Experiences
NCT05967494 ·Status: NOT_YET_RECRUITING
-
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
NCT06504589 ·Status: RECRUITING